ApplicationSan Francisco, California, USAFounded 2011· One of 381 Application companies tracked by AMPulse
Produces cultivated meat using bioprinting and cellular agriculture technology, creating real animal meat from cells without slaughtering animals.
CEO / Founder
Josh Tetrick
Team Size
201-500
Stage
Active
Total Funding
$267M
Latest Round
Corporate Round
Key Investors
GTCC Wealth; One One Five Group of Companies; Bill Gates; Marc Benioff; Qatar Investment Authority; U.S. Department of Agriculture; C2 Capital; Qatar Free Zones Authority
Technology & Products
Key Products
Cultivated meat (chicken, beef); JUST Egg (plant-based egg substitute)
Technological Advantage
First-mover advantage with regulatory approvals in Singapore and the U.S.; proprietary cell culture and bioprinting technology for scalable meat production
Differentiation
Value Proposition
Provides real meat without environmental impact or animal slaughter, offering a sustainable alternative with identical taste and texture to conventional meat.
How They Differentiate
First-to-market with regulatory approvals; focuses on cultivated meat rather than plant-based alternatives; uses bioprinting for structured meat products
Market & Competition
Target Customers
Restaurants, retailers, and consumers seeking sustainable and ethical meat alternatives
Industry Verticals
Food and Beverage; Biotechnology; Sustainable Agriculture
Competitors
Upside Foods; Believer Meats; Mosa Meat
Growth & Milestones
Growth Metrics
First cultivated meat company to receive U.S. FDA clearance; products sold in Singapore and U.S. restaurants
Major Milestones
First regulatory approval in Singapore (2020); U.S. FDA clearance (2023); First U.S. restaurant service at China Chilcano (2023); First retail sales at Huber's Butchery
GOOD Meat, a division of Eat Just, occupies a distinctive position as the world's first company to receive regulatory approval to sell cultivated meat. Founded in 2011 and based in San Francisco, the company addresses the environmental and ethical costs of conventional animal agriculture by growing meat directly from animal cells, bypassing the need for raising and slaughtering livestock. Its product line includes cultivated chicken and beef, alongside the plant-based JUST Egg brand, which provides a separate revenue stream in the alternative protein market.
The core technology combines cellular agriculture with bioprinting, specifically material extrusion (MEX) methods, to produce structured meat products. GOOD Meat's proprietary cell culture and bioprinting processes aim to replicate the texture and taste of conventional meat at scale. The company holds multiple patents covering bioprinting methods for cultivated meat production, including scaffold-free three-dimensional bioprinting techniques.
GOOD Meat targets restaurants, retailers, and consumers seeking sustainable and ethical meat alternatives. Notable early customers include China Chilcano by José Andrés in Washington, D.C., and Huber's Butchery in Singapore, where the product first launched. The company has secured regulatory clearances in Singapore (2020) and from the U.S. FDA (2023), giving it a first-mover advantage over competitors like Upside Foods, Believer Meats, and Mosa Meat.
Key partnerships with ADM and ABEC support production scale-up, while investors including Bill Gates, Marc Benioff, and the Qatar Investment Authority have contributed to $1.21 billion in total funding. A critical open question is whether GOOD Meat can reduce production costs to price parity with conventional meat and achieve the manufacturing volumes needed for widespread retail distribution.
Competitive Intelligence
Competitors, SWOT analysis, and investment insights